FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective than conventional medical management in the treatment ... Devices, Neurology, FDA Abbott, spinal cord stimulation, diabetic peripheral neuropathy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news